Protein A Resins Market (By Application: Antibody purification, Immunoprecipitation; By Product: Recombinant protein A, Natural protein A; By Matrix Type: Agarose-based matrix, Glass or silica gel-based matrix, Organic polymer-based matrix; By End-user: Pharmaceutical & Biopharmaceutical Companies, Clinical research laboratories, Academic research institutes, Contract research organization) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein A Resins Market 

5.1. COVID-19 Landscape: Protein A Resins Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein A Resins Market, By Application

8.1. Protein A Resins Market Revenue and Volume Forecast, by Application, 2024-2033

8.1.1. Antibody purification

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Immunoprecipitation

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Protein A Resins Market, By Product

9.1. Protein A Resins Market Revenue and Volume Forecast, by Product, 2024-2033

9.1.1. Recombinant protein A

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Natural protein A

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Protein A Resins Market, By Matrix Type 

10.1. Protein A Resins Market Revenue and Volume Forecast, by Matrix Type, 2024-2033

10.1.1. Agarose-based matrix

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Glass or silica gel-based matrix

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Organic polymer-based matrix

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Protein A Resins Market, By End-user 

11.1. Protein A Resins Market Revenue and Volume Forecast, by End-user, 2024-2033

11.1.1. Pharmaceutical & Biopharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Clinical research laboratories

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Academic research institutes

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Contract research organization

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Protein A Resins Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Matrix Type (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Merck Millipore

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PerkinElmer, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. GenScript Biotech Corp.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Agilent Technologies

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Repligen Corp.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Thermo Fisher Scientific Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bio-Rad Laboratories, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Abcam PLC.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Novasep Holdings SAS

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample